LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | AZD 5438 | 3.33 | uM | LJP6 | 1 | J02 | 72 | hr | 1097 | 796 | 3610 | 0.2205 | -0.1704 |
BT-20 | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 1097 | 774 | 3713 | 0.2084 | -0.1800 |
BT-20 | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 1097 | 715 | 3696 | 0.1934 | -0.2168 |
BT-20 | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 1097 | 525 | 3610 | 0.1454 | -0.3488 |
BT-20 | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 1097 | 536 | 3713 | 0.1443 | -0.3346 |
BT-20 | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 1097 | 559 | 3696 | 0.1512 | -0.3195 |
BT-20 | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 1097 | 3281 | 3735 | 0.8784 | 0.8585 |
BT-20 | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 1097 | 3582 | 3877 | 0.9237 | 0.9147 |
BT-20 | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 1097 | 3581 | 3925 | 0.9123 | 0.9026 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 1097 | 2967 | 3735 | 0.7943 | 0.7557 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 1097 | 2836 | 3877 | 0.7314 | 0.6843 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 1097 | 3393 | 3925 | 0.8644 | 0.8476 |
BT-20 | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 1097 | 3078 | 3735 | 0.8241 | 0.7926 |
BT-20 | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 1097 | 3103 | 3877 | 0.8002 | 0.7696 |
BT-20 | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 1097 | 3018 | 3925 | 0.7688 | 0.7336 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 1097 | 2749 | 3735 | 0.7360 | 0.6815 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 1097 | 2633 | 3877 | 0.6790 | 0.6170 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 1097 | 2908 | 3925 | 0.7408 | 0.6989 |
BT-20 | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 1097 | 2312 | 3735 | 0.6190 | 0.5246 |
BT-20 | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 1097 | 2161 | 3877 | 0.5573 | 0.4508 |
BT-20 | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 1097 | 2295 | 3925 | 0.5847 | 0.4937 |
BT-20 | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 1097 | 714 | 3735 | 0.1912 | -0.2158 |
BT-20 | Pelitinib | 10 | uM | LJP5 | 2 | I13 | 72 | hr | 1097 | 857 | 3877 | 0.2210 | -0.1269 |
BT-20 | Pelitinib | 10 | uM | LJP5 | 3 | I13 | 72 | hr | 1097 | 852 | 3925 | 0.2171 | -0.1285 |
BT-20 | Luminespib | 0.04 | uM | LJP5 | 1 | H18 | 72 | hr | 1097 | 1124 | 3735 | 0.3009 | 0.0137 |